A case of iron overload cardiomyopathy: Beneficial effects of iron chelating agent and calcium channel blocker on left ventricular dysfunction

International Heart Journal

Volumn 50, Issue 6, 2009, Pages 829-838

  Sugishita, Kazuro ^a   Asakawa, Masako ^a   Usui, Shin Ichi ^a   Takahashi, Toshiyuki ^a  

^a JR Tokyo General Hospital   (Japan)

Author keywords

Negative force frequency relationship; Total ejection isovolume index

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CANDESARTAN; DEFEROXAMINE; FERRITIN; FUROSEMIDE; HEMOSIDERIN; SPIRONOLACTONE; VERAPAMIL;

ADD ON THERAPY; AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOMYOPATHY; CASE REPORT; CELL DAMAGE; ECHOCARDIOGRAPHY; FERRITIN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HUMAN; IRON OVERLOAD; IRON OVERLOAD CARDIOMYOPATHY; LUNG ARTERY PRESSURE; MACROCYTIC ANEMIA; MALE; PRIORITY JOURNAL;

AGED, 80 AND OVER; CALCIUM CHANNEL BLOCKERS; CARDIOMYOPATHIES; DEFEROXAMINE; FERRITINS; HUMANS; IRON CHELATING AGENTS; IRON OVERLOAD; MALE; VENTRICULAR DYSFUNCTION, LEFT; VERAPAMIL;

EID: 74049102074     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.50.829     Document Type: Article

References (13)

1. Tsushima RG, Wickenden AD, Bouchard RA, Oudit GY, Liu PR Backx PH. Modulation of iron up-take in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. Circ Res 1999; 84: 1302-9.
2. 2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy. Nat Med 2003; 9: 1187-94.
3. 2+ channels in iron transport and iron-overload cardiomyopathy. J Mol Med 2006; 84: 349-64.
4. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radie Biol Med 2002; 32: 833-40. (Review)
5. Cherednichenko G, Zima AV, Feng W, Schaefer S, Blatter LA, Pessah IN. NADH oxidase activity of rat cardiac sarcoplasmic reticulum regulates calcium-induced calcium release. Circ Res 2004; 94: 478-86.
6. Goldhaber JI, Qayyum MS. Oxygen free radicals and excitation-contraction coupling. Antioxid Redox Signal 2000; 2: 55-64. (Review)
7. Lacampagne A, Duittoz A, Bolaños P, Peineau N, Argibay JA. Effect of sulfhydryl oxidation on ionic and gating currents associated with L-type calcium channels in isolated guinea-pig ventricular myocytes. Cardiovasc Res 1995; 30: 799-806.
8. Buja LM, Roberts WC. Iron in the heart. Etiology and clinical significance. AM J Med 1971; 51: 209-21.
9. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28: 658-64.
10. 2+ channels. J Clin Invest 2004; 113: 1430-9.
11. 2+ identified by patch-clamp recording in rat liver cells. Hepatology 2001; 33: 938-47.
12. Rahko PS, Salerai R, Uretsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol 1986; 8: 436-40.
13. Peng CT, Tsai CH, Wu KH. Effects of chelation therapy on cardiac function improvement in thalassemia patients: literature review and the Taiwanese experience. Hemoglobin 2008; 32: 49-62. (Review)